Basain VJM, Valdés AMC, Pérez MM, Jorge DMÁ, Linares VH

Language: Spanish
References: 16
Page: 74-80
PDF size: 90.09 Kb.

ABSTRACT

Obesity is a chronic disease characterized by a pathological rise of body fat generated by an imbalance between energy input and output. This energy excess is stored in the adipose tissue which not only stores lipids but also secretes numerous hormones and represents the biggest endocrine organ of the human body. Unlike other endocrine glands, it has a variable mass and may gradually increase or decrease its size depending on age, food intake, physical activity, perinatal scheduling and genetic predisposition. Among the secreted factors are leptin which participates in the regulation of energy balance and the gonadotropin secretions. The objective of this literature review was to describe the role of leptin as afferent signal in the regulation of energy homeostasis; its importance as one of the mechanisms involved in obesity pathogenesis was underlined.

REFERENCES

1. Baudrand BR, Arteaga UE, Moreno GM. El tejido graso como modulador endocrino: Cambios hormonales asociados a la obesidad. Rev Méd Chile. 2010;138(10):1294- 301.

2. Brito Portuondo CA, Hernández Perera JC, Sánchez López L. Efectos de la obesidad sobre la función cardiovascular, respiratoria e inflamatoria. Invest Medicoquir. 2012;4(2):227-33.

3. Gómez-Hernández A, Perdomo L, Escribano O, Benito M. Papel del tejido adiposo blanco en las complicaciones vasculares asociadas a la obesidad. Clínica e Investigación en Arteriosclerosis. 2013;25(01):27-35.

4. Fortis A, García-Macedo R, Maldonado-Bernal C, Alarcón-Aguilar F, Cruz M. El papel de la inmunidad innata en la obesidad. Salud Pública Méx. 2012;54(2):171-7.

5. Nava Reyes HJ, Zamudio Cortés P, García Cruz A, Noyola Ugalde MC, Pizaña Venegas A, Hernández Jiménez C, et al. Papel del adipocito en la expresión del factor inducible por hipoxia (HIF) asociado a la obesidad. Neumol Cir Torax. 2011;70(4):261-6.

6. Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf). 2012;205:194-208.

7. Vega Robledo GB. El adipocito y la respuesta inmune. Rev Fac Med UNAM. 2010;53(1):43-5.

8. Franchini M, Monnais E, Seboek D, Radimerski T, Zini E, Kaufmann K, et al. Insulin resistance and increased lipolysis in bone marrow derived adipocytes stimulated with agonists of Toll-like receptors. Horm Metab Res. 2010;42:703-9.

9. Fresno M, Alvarez R, Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem. 2011;117:151-64.

10. Manuel L, Zárate A, Hernández-Valencia M. La leptina, hormona del adipocito, regula el apetito y el consumo de energía. Papel en la obesidad y dismetabolismo. Acta Médica Grupo Ángeles. 2012;10(3):154-7.

11. Coleman DL. A historical perspective on leptin. Nature Medicine. 2010;16:1097-9.

12. Friedman JM, Zhang Y, Proenca R, Maffei M, Barone M, Leopold L. Positional cloning of mouse obese gene and its human homologue. Nature. 1994;372:425-31.

13. Reyes JM. Características biológicas del tejido adiposo: el adipocito como célula endocrina. Rev Med Clin Condes. 2012;23(2):136-44.

14. Galgani J, Ravussin E. Principles of human energy metabolism. En: Ahima R. Metabolic basis of obesity. Philadelphia: Editorial Springer; 2011. p. 1-24.

15. Kopp A, Buechler C, Bala M, Neumeier M, Schölmerich J, Schäffler A. Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3. Endocrinology. 2010;151:1097-108.

16. Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010;14:1419- 31.